# Illumina, Inc.: Form 10-K for the period ended Dec 31, 2023

- Company: [Illumina, Inc.](/companies/ilmn.md) (CIK 1110803)
- Form: 10-K
- Filed: 2024-02-16
- Accepted by EDGAR: Feb 16, 2024, 16:21 ET
- Period: 2023-12-31
- Accession: 0001110803-24-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1110803/000111080324000010/ilmn-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1110803/000111080324000010/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-02 to 2023-12-31 | $4.50bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2023-01-02 to 2023-12-31 | $1.76bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2023-01-02 to 2023-12-31 | $2.74bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2023-01-02 to 2023-12-31 | $1.35bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2023-01-02 to 2023-12-31 | $1.61bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2023-01-02 to 2023-12-31 | −$1.07bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-01-02 to 2023-12-31 | $77.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-01-02 to 2023-12-31 | $44.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-02 to 2023-12-31 | −$1.16bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-01-02 to 2023-12-31 | −$7.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-02 to 2023-12-31 | −$7.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-02 to 2023-12-31 | 158,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-02 to 2023-12-31 | $478.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-02 to 2023-12-31 | $195.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | at 2023-12-31 | $2.61bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $10.11bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $1.57bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2023-12-31 | $5.75bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1110803/000111080324000010/ilmn-20231231.htm

Filed Feb 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001110803-24-000010. Last ingested by Listed: Nov 14, 2026, 13:59 ET. No prices; not investment advice.
